Elaine M. Castilow, Ph.D. - Publications

Affiliations: 
2008 University of Iowa, Iowa City, IA 
Area:
Immunology, Virology Biology

8 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2009 Meyerholz DK, Rodgers J, Castilow EM, Varga SM. Alcian Blue and Pyronine Y histochemical stains permit assessment of multiple parameters in pulmonary disease models. Veterinary Pathology. 46: 325-8. PMID 19261646 DOI: 10.1354/Vp.46-2-325  0.604
2009 Meyerholz DK, Griffin MA, Castilow EM, Varga SM. Comparison of histochemical methods for murine eosinophil detection in an RSV vaccine-enhanced inflammation model. Toxicologic Pathology. 37: 249-55. PMID 19181630 DOI: 10.1177/0192623308329342  0.58
2008 Castilow EM, Varga SM. Overcoming T cell-mediated immunopathology to achieve safe RSV vaccination. Future Virology. 3: 445-454. PMID 19057653 DOI: 10.2217/17460794.3.5.445  0.682
2008 Castilow EM, Legge KL, Varga SM. Cutting edge: Eosinophils do not contribute to respiratory syncytial virus vaccine-enhanced disease. Journal of Immunology (Baltimore, Md. : 1950). 181: 6692-6. PMID 18981084 DOI: 10.4049/Jimmunol.181.10.6692  0.691
2008 Castilow EM, Meyerholz DK, Varga SM. IL-13 is required for eosinophil entry into the lung during respiratory syncytial virus vaccine-enhanced disease. Journal of Immunology (Baltimore, Md. : 1950). 180: 2376-84. PMID 18250447 DOI: 10.4049/Jimmunol.180.4.2376  0.688
2008 Castilow EM, Olson MR, Meyerholz DK, Varga SM. Differential role of gamma interferon in inhibiting pulmonary eosinophilia and exacerbating systemic disease in fusion protein-immunized mice undergoing challenge infection with respiratory syncytial virus. Journal of Virology. 82: 2196-207. PMID 18094193 DOI: 10.1128/Jvi.01949-07  0.664
2007 Castilow EM, Olson MR, Varga SM. Understanding respiratory syncytial virus (RSV) vaccine-enhanced disease. Immunologic Research. 39: 225-39. PMID 17917067 DOI: 10.1007/S12026-007-0071-6  0.71
2007 Monick MM, Powers LS, Hassan I, Groskreutz D, Yarovinsky TO, Barrett CW, Castilow EM, Tifrea D, Varga SM, Hunninghake GW. Respiratory syncytial virus synergizes with Th2 cytokines to induce optimal levels of TARC/CCL17. Journal of Immunology (Baltimore, Md. : 1950). 179: 1648-58. PMID 17641031 DOI: 10.4049/Jimmunol.179.3.1648  0.655
Show low-probability matches.